Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
2
currently held
Exits tracked
2
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin4 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Synthon BC European Capital X | BC Partners | 2019 | 5yr | Exited 2024 | Goldman Sachs Alternatives | – | |||
OctoPlus FPCI Entreprise & Croissance I | Generis Capital Partners | 2011 | 2yr | Exited 2013 | Dr Reddy's Laboratories | – | |||
InnoSyn Mérieux Innovation 1 | Merieux Equity Partners | 2023 | 3yr | Active | – | – | |||
Basic Pharma SHS VI | SHS Gesellschaft für Beteiligungsmanagement | 2026 | 0yr | Active | – | – |
Synthon
BC European Capital X
Sector
Pharma
InvestorBC Partners
Entry
2019
Hold
5yr
Exit
2024
to Goldman Sachs Alternatives
OctoPlus
FPCI Entreprise & Croissance I
Sector
Pharma
InvestorGeneris Capital Partners
Entry
2011
Hold
2yr
Exit
2013
to Dr Reddy's Laboratories
InnoSyn
Mérieux Innovation 1
Sector
Pharma
InvestorMerieux Equity Partners
Entry
2023
Hold
3yr
Basic Pharma
SHS VI
Sector
Pharma
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2026
Hold
0yr